TerminatedPhase 2NCT01709474
Vitamin D3 Treatment in Pediatric Systemic Lupus Erythematosus
Studying Pediatric systemic lupus erythematosus
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Principal Investigator
- Jon M Burnham, MD, MSCEUniversity of Pennsylvania
- Intervention
- Vitamin D3 6000 IU(drug)
- Enrollment
- 7 enrolled
- Eligibility
- 5-20 years · All sexes
- Timeline
- 2013 – 2014
Study locations (13)
- Children's Hospital Los Angeles, Los Angeles, California, United States
- Lucile Packard Children's Hospital, Stanford University, Palo Alto, California, United States
- UCSF School of Medicine, San Francisco, California, United States
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
- University of Chicago, Chicago, Illinois, United States
- Riley Hospital for Children, Indianapolis, Indiana, United States
- Columbia University, New York, New York, United States
- University of Rochester, Rochester, New York, United States
- Montefiore Medical Center, The Bronx, New York, United States
- Duke University Medical Center, Durham, North Carolina, United States
- The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
- Children's Medical Center of Dallas, Dallas, Texas, United States
- Seattle Children's Hospital, Seattle, Washington, United States
Collaborators
Autoimmunity Centers of Excellence
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01709474 on ClinicalTrials.govOther trials for Pediatric systemic lupus erythematosus
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07425730Early Myocardial Dysfunction Helps Identify Severe Refractory Pediatric LupusShanghai Jiao Tong University School of Medicine
- RECRUITINGNCT07128966Direct to Patient Minimal Risk Biospecimen and Data Collection ResearchJoined Bio
- RECRUITINGPHASE2NCT05538208The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) StudyChildren's Hospital Medical Center, Cincinnati
- RECRUITINGPHASE3NCT05835310An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric ParticipantsAstraZeneca
- RECRUITINGNANCT06586710Interferon Pathway Activation in Monogenic and Nonmonogenic Forms of Pediatric SLEMeyer Children's Hospital IRCCS
- RECRUITINGPHASE2NCT05039619A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric ParticipantsHoffmann-La Roche
- ACTIVE NOT RECRUITINGPHASE2NCT04179032Study of Subcutaneous (SC) Belimumab in Pediatric Participants With Systemic Lupus Erythematosus (SLE)GlaxoSmithKline